1. 751PEffects of random glucose (Glc) levels on outcomes of patients (pts) with pancreatic ductal adenocarcinoma (PDAC). (23rd October 2018) Authors: Pihlak, R; Almond, R; Srivastava, P; Raja, H; Broadbent, R; Hopewell, L; Higham, C; Lamarca, A; Hubner, R; Valle, J W; McNamara, M G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). Issue 2 (5th February 2020) Authors: Craig, Zoe; Swain, Jayne; Batman, Emma; Wadsley, Jonathan; Reed, Nicholas; Faluyi, Olusola; Cave, Judith; Sharma, Rohini; Chau, Ian; Wall, Lucy; Lamarca, Angela; Hubner, R; Mansoor, Wasat; Sarker, Debashis; Meyer, Tim; Cairns, David A; Howard, Helen; Valle, Juan W; McNamara, Mairéad G Journal: BMJ open Issue: Volume 10:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O-021Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH). (2nd July 2019) Authors: Meyer, T; Finn, R; Kudo, M; Kang, Y; Yen, C; Galle, P; Llovet, J; Assenat, E; Brandi, G; Motomura, K; Okusaka, T; Hubner, R; Karwal, M; Baron, A; Ikeda, M; Liang, K; Wang, C; Widau, R; Schelman, W; Zhu, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P-007Neoadjuvant FLOT: Real world toxicity from a specialist UK centre. (20th June 2018) Authors: Kordatou, Z; Papaxoinis, G; Waddell, T; Owen-Holt, V; Weaver, J; Hubner, R; Mansoor, W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P-007Neoadjuvant FLOT: Real world toxicity from a specialist UK centre. (20th June 2018) Authors: Kordatou, Z; Papaxoinis, G; Waddell, T; Owen-Holt, V; Weaver, J; Hubner, R; Mansoor, W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P-11730-day mortality associated with systemic anti-cancer therapy (SACT) in gastrointestinal malignancies: The Christie experience. (20th June 2018) Authors: Marti, F Marti; McGurk, A; Alam, N; Bhatt, L; Braun, M; Hubner, R; Mansoor, W; McBain, C; McNamara, M; Mullamitha, S; Saunders, M; Sheikh, H; Thistlethwaite, F; Valle, J; Wilson, G; Hasan, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗